Publications by authors named "Richard Pollak"

Claim this Profile
H
Human Placenta-Derived Cells (PDA-002) in Diabetic Foot Ulcer Patients With and Without Peripheral Artery Disease: A Phase 2 Multi-Center, Randomised, Double-Blind, Placebo-Controlled Trial.
Richard Pollak, James Anderson, Bert Altmanshofer, Joseph Caporusso, Gary Fantini

Int Wound J· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective Inhibition of Na1.8 with VX-548 for Acute Pain.
Jim Jones, Darin J Correll, Sandra M Lechner, Ina Jazic, Xiaopeng Miao, Richard A Pollak

N Engl J Med· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Opioid-Free Recovery from Bunionectomy with HTX-011, a Dual-Acting Local Anesthetic Combining Bupivacaine and Meloxicam, as the Foundation of Non-Opioid Multimodal Analgesia.
Richard Pollak, Danlin Cai, Tong J Gan

J Am Podiatr Med Assoc· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to the letter to the editor by Hafer and Johnson concerning 'Mechanism of action of HTX-011: a novel, extended-release, dual-acting local anesthetic formulation for postoperative pain'.
Thomas Ottoboni, Barry Quart, Jayne Pawasauskas, Joseph F Dasta, Richard A Pollak

Reg Anesth Pain Med· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Intravenously Administered Tramadol in Patients with Moderate to Severe Pain Following Bunionectomy: A Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study.
Neil K Singla, Richard Pollak, Ira Gottlieb, David Leiman, Harold Minkowitz

Pain Ther· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HTX-011 Reduced Pain and Opioid Use After Primary Total Knee Arthroplasty: Results of a Randomized Phase 2b Trial.
Paul F Lachiewicz, Gwo-Chin Lee, Richard A Pollak, David G Leiman, Jia Hu

J Arthroplasty· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanism of action of HTX-011: a novel, extended-release, dual-acting local anesthetic formulation for postoperative pain.
Thomas Ottoboni, Barry Quart, Jayne Pawasauskas, Joseph F Dasta, Richard A Pollak

Reg Anesth Pain Med· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Intravenous Meloxicam in Patients With Moderate-to-Severe Pain Following Bunionectomy: A Randomized, Double-Blind, Placebo-controlled Trial.
Richard A Pollak, Ira J Gottlieb, Fardin Hakakian, John C Zimmerman, Stewart W McCallum

Clin J Pain· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Follow-up of Onychomycosis Patients Treated With Efinaconazole.
Richard A Pollak, Carla Ilie

J Drugs Dermatol· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of intramuscular human placenta-derived mesenchymal stromal-like cells (cenplacel [PDA-002]) in patients who have a diabetic foot ulcer with peripheral arterial disease.
Stephanie C Wu, Richard Pollak, Robert G Frykberg, Wei Zhou, Maha Karnoub

Int Wound J· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defining the optimal formulation and schedule of a candidate toxoid vaccine against Clostridium difficile infection: A randomized Phase 2 clinical trial.
Guy de Bruyn, Jamshid Saleh, David Workman, Richard Pollak, Victor Elinoff

Vaccine· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of tavaborole topical solution, 5%, a novel boron-based antifungal agent, for the treatment of toenail onychomycosis: Results from 2 randomized phase-III studies.
Boni E Elewski, Raza Aly, Sheryl L Baldwin, Remigio F González Soto, Phoebe Rich, Richard Pollak

J Am Acad Dermatol· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efinaconazole Topical Solution, 10%: Factors Contributing to Onychomycosis Success.
Richard A Pollak, William J Jo Siu, Yoshiyuki Tatsumi, Radhakrishnan Pillai

J Fungi (Basel)· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efinaconazole topical solution, 10%: the development of a new topical treatment for toenail onychomycosis.
Richard A Pollak

J Am Podiatr Med Assoc· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Access of efinaconazole topical solution, 10%, to the infection site by spreading through the subungual space.
Boni E Elewski, Richard A Pollak, Radhakrishnan Pillai, Jason T Olin

J Drugs Dermatol· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The efficacy and safety of tavaborole, a novel, boron-based pharmaceutical agent: phase 2 studies conducted for the topical treatment of toenail onychomycosis.
Mirna E Toledo-Bahena, Alicia Bucko, Jorge Ocampo-Candiani, Maira E Herz-Ruelas, Terry M Jones, Richard A Pollak

J Drugs Dermatol· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of high-dose versus standard-dose influenza vaccine in older adults.
Carlos A DiazGranados, Andrew J Dunning, Murray Kimmel, Daniel Kirby, John Treanor, Richard Pollak

N Engl J Med· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of once-daily luliconazole 1% cream in patients ≥12 years of age with interdigital tinea pedis: a phase 3, randomized, double-blind,vehicle-controlled study.
Michael Jarratt, Terry Jones, Jeffrey Adelglass, Alicia Bucko, Richard Pollak

J Drugs Dermatol· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efinaconazole 10% solution in the treatment of toenail onychomycosis: Two phase III multicenter, randomized, double-blind studies.
Boni E Elewski, Phoebe Rich, Richard Pollak, David M Pariser, Shinichi Watanabe

J Am Acad Dermatol· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toenail assessment tool for quantitation of visibly infected mycotic nail plate in onychomycosis.
Amir Tavakkol, Richard Pollak, Lawrence Harkless, Karry-Ann Shebetka, Max Weisfeld

Cutis· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analgesic efficacy of valdecoxib for acute postoperative pain after bunionectomy.
Richard Pollak, Gary A Raymond, Richard M Jay, Howard J Hillstrom, Kieran T Mahan

J Am Podiatr Med Assoc· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of toenail onychomycosis with oral terbinafine plus aggressive debridement: IRON-CLAD, a large, randomized, open-label, multicenter trial.
Maureen B Jennings, Richard Pollak, Lawrence B Harkless, Farid Kianifard, Amir Tavakkol

J Am Podiatr Med Assoc· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An open-label, randomized study comparing efficacy and safety of intravenous piperacillin/tazobactam and ampicillin/sulbactam for infected diabetic foot ulcers.
Lawrence Harkless, Jack Boghossian, Richard Pollak, Wayne Caputo, Adrian Dana

Surg Infect (Larchmt)· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trial.
William A Marston, Jason Hanft, Paul Norwood, Richard Pollak,

Diabetes Care· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A bitter pill for epileptics.
Richard Pollak

N Y Times Web· September 1986

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis